GlassScriptPhysician profile
Victoria Flower
NPI 1841423449
$105,780.91
in general payments reported to CMS, 2019-2025
13 companies · $40K in 2025
The $40K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,384 · 2022: $3,212 · 2023: $33K · 2024: $28K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Travel and Lodging: $24K · Consulting Fee: $13K · Food and Beverage: $11K · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,331.50 |
| Travel and Lodging | $23,831.78 |
| Consulting Fee | $12,937.50 |
| Food and Beverage | $10,966.65 |
| Education | $117.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $81,421.99 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Spr Therapeutics, INC | $13,395.56 | 2021-2025 | Sprint Pns System |
| Nalu Medical, INC. | $7,467.41 | 2022-2025 | Nalu Neurostimulation System |
| Mml US, INC. | $771.78 | 2021 | |
| Boston Scientific Corporation | $618.67 | 2021-2025 | Infinion 16, Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $552.45 | 2021-2024 | Eterna, Proclaim |
| Relievant Medsystems, INC. | $450.70 | 2021-2023 | Intracept |
| Biotronik Nro, INC. | $339.66 | 2023-2024 | Biotronik, Prospera |
| Si-Bone, INC. | $269.10 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $164.04 | 2024-2025 | |
| Saluda Medical Americas, INC. | $139.14 | 2023-2024 | Evoke Scs, Evoke |
| Nevro Corp. | $119.16 | 2022-2024 | Senza |
| Vertos Medical, INC. | $71.25 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Flower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.